GILZRx

GILZRx is developing an anti-inflammatory therapeutic small molecule for the treatment of inflammatory and autoimmune diseases, including lupus. This novel approach can reduce reliance on glucocorticoids for treatment, potentially minimising a variety of side-effects and making a tangible difference in people’s lives.

Year Established: 2023
Lead Researchers: Sarah Jones and Eric Morand